HKSH's First-in-Asia Comparative Study on Radiotherapy for Breast Cancer Reveals Hypofractionated Proton Therapy Prevents Breast Cancer Recurrence with 100% Survival Rate

HKSH's First-in-Asia Comparative Study on Radiotherapy for Breast Cancer Reveals Hypofractionated Proton Therapy Prevents Breast Cancer Recurrence with 100% Survival Rate

Minimises Cardiopulmonary Concerns and Maintains Quality of Life HONG KONG, July 7, 2026 /PRNewswire/ -- The HKSH Cancer Centre under HKSH Medical Group (HKSH) introduced proton therapy in 2023, covering a wide range of cancer types including...

69 ESG Champions Recognized at the Asia Responsible Enterprise Awards (AREA) 2026 for Shaping a Regenerative and Inclusive Tomorrow

69 ESG Champions Recognized at the Asia Responsible Enterprise Awards (AREA) 2026 for Shaping a Regenerative and Inclusive Tomorrow

KUALA LUMPUR, Malaysia, July 2, 2026 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2026 honored 69 outstanding ESG champions for leveraging innovation, digital transformation, and responsible business practices to drive sustainable...

NextRise 2026, Seoul Successfully Wraps Up as Asia's Leading Startup Fair Co-hosted by KITA and KDB

NextRise 2026, Seoul Successfully Wraps Up as Asia's Leading Startup Fair Co-hosted by KITA and KDB

SEOUL, South Korea, June 26, 2026 /PRNewswire/ -- The Korea International Trade Association (KITA) and Korea Development Bank (KDB) successfully wrapped up NextRise 2026, Seoul, Asia's leading startup fair, at COEX in Samseong-dong, Seoul, after a...

Avinox Unveils the Avinox MG Concept Product at Eurobike 2026

Avinox Unveils the Avinox MG Concept Product at Eurobike 2026

Developed in collaboration with Canyon, Commencal, Forbidden, Mondraker, and Megamo FRANKFURT, Germany, June 24, 2026 /PRNewswire/ -- Avinox, the e-bike systems company building integrated technology to power the next generation of electric...

Ligufalimab (CD47)-Based Combination Achieves Deep Responses and Survival Benefit in Frontline AML: Phase II Results Presented in Oral Session at EHA 2026

Ligufalimab (CD47)-Based Combination Achieves Deep Responses and Survival Benefit in Frontline AML: Phase II Results Presented in Oral Session at EHA 2026

HONG KONG, June 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) were presented...

Over a Thousand Developers Pursue the Dream of Open Computing! FlagOS Open Computing Global Challenge Season 1 Award Ceremony Featured at the 8th BAAI Conference

Over a Thousand Developers Pursue the Dream of Open Computing! FlagOS Open Computing Global Challenge Season 1 Award Ceremony Featured at the 8th BAAI Conference

BEIJING, June 16, 2026 /PRNewswire/ -- On June 13, the award ceremony for the FlagOS Open Computing Global Challenge (Season 1), jointly organized by the Beijing Academy of Artificial Intelligence (BAAI) and the FlagOS Community, was held during the...

ACON OPTICS (TWSE: 6820) Strengthens AI High-Speed Interconnect Portfolio with CPO and 1.6T Connectivity Technologies at COMPUTEX 2026

ACON OPTICS (TWSE: 6820) Strengthens AI High-Speed Interconnect Portfolio with CPO and 1.6T Connectivity Technologies at COMPUTEX 2026

TAIPEI, June 16, 2026 /PRNewswire/ -- ACON OPTICS (TWSE: 6820), a leading provider of advanced optical connectivity solutions, showcased its latest innovations in AI optical interconnect technologies at COMPUTEX 2026 under the theme "Shaping...

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24. Post-hoc...

As AI Infrastructure Takes Center Stage, Neurovia AI Highlights NeuroStream™ and New Leadership at UAE Industry Summit

As AI Infrastructure Takes Center Stage, Neurovia AI Highlights NeuroStream™ and New Leadership at UAE Industry Summit

ABU DHABI, UAE, June 11, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) announced that its wholly-owned subsidiary, Neurovia AI, officially participated in the 2026 UAE Data Center Infrastructure & Cloud Summit as an OFFICIAL AI INFRASTRUCTURE...

HKC, ANTGAMER, KOORUI Make Strong Debut at COMPUTEX 2026 with World-First Display Innovations

HKC, ANTGAMER, KOORUI Make Strong Debut at COMPUTEX 2026 with World-First Display Innovations

TAIPEI, June 10, 2026 /PRNewswire/ -- HKC, ANTGAMER, and KOORUI have successfully concluded their presence at COMPUTEX 2026. Under the theme "Win Beyond the Frame," the three brands unveiled multiple world-first display products and advanced...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • menu
    menu